Propanc Biopharma, Inc.: Form 10-Q for the period ended Mar 31, 2012
Filed with the SEC on May 21, 2012 and accepted by EDGAR at May 21, 2012, 11:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 9 months2011-07-01 to 2012-03-31 | $5.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2012-01-01 to 2012-03-31 | −$3.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-07-01 to 2012-03-31 | −$9.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-01-01 to 2012-03-31 | $1.1k | us-gaap:InterestExpense |
| Interest expense | 9 months2011-07-01 to 2012-03-31 | $1.9k | us-gaap:InterestExpense |
| Income tax | 9 months2011-07-01 to 2012-03-31 | −$175.2k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-01-01 to 2012-03-31 | −$3.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2011-07-01 to 2012-03-31 | −$8.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-01-01 to 2012-03-31 | −$0.04 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2011-07-01 to 2012-03-31 | −$0.12 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2011-07-01 to 2012-03-31 | −$114.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2012-03-31 | $2.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-03-31 | $2.2m | us-gaap:Assets |
| Current liabilities | At period end2012-03-31 | $482.2k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-03-31 | $482.2k | us-gaap:Liabilities |
| Shareholders' equity | At period end2012-03-31 | $1.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-12-002768. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.